Delivery Order SPE2DB25D3402-SPE2DB25FUGAB
Award Date 3/11/25
Potential Completion Date 3/12/25
Potential Value $3.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,489.90, is for the delivery of Losartan-HCTZ 50-12.5 mg tablets in 90-count packages. The contract is a firm fixed-price delivery order with a completion date of March 14, 2025. This contract is not designated as a set-aside. AmerisourceBergen also holds a larger Indefinite Delivery Contract (IDC)...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,895.96, is a Firm Fixed Price Delivery Order for the supply of Losartan-HCTZ 50-12.5 mg tablets. The contract has an ultimate completion date of January 17, 2025 and is not associated with any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,656.91, is for the delivery of Losartan-HCTZ 100-25 mg tablets. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 28, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a $1,903.12 Firm Fixed Price Delivery Order for the supply of Losartan-HCTZ 50-12.5 mg tablets. The contract has an ultimate completion date of March 6, 2025 and was awarded on March 5, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,124.82, is for the delivery of 4567666896 Losartan-HCTZ 50-12.5 mg tablets in 90-count packages. The contract has an ultimate completion date of March 24, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal delivery order contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $11,544.06, is for the supply of Losartan-HCTZ 100-12.5 mg tablets in 90-count packages. The contract has a completion date of September 24, 2024 and is a Firm Fixed Price delivery order. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Losartan-HCTZ 100-12.5 mg tablets in 90-count bottles. The contract has an ultimate completion date of August 1, 2024 and a ceiling value of $36,216.38. The contract is not associated with any set-aside program. As a major pharmaceutical distributor, Amerisourcebergen has been awarded numerous federal contracts by the DLA and other agencies to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,436.44 firm fixed-price delivery order contract (SPE2DX15D3015|SPE2DX24F0EN0) to AmerisourceBergen Drug Corp for the supply of 4,563,434,205 units of Losartan-HCTZ 50-12.5 mg tablets. This delivery order is part of a larger $999,999,999 indefinite delivery contract (IDC) held by AmerisourceBergen with the DLA, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
- This federal contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $20,808.22 and is for the delivery of Losartan-HCTZ 100-12.5 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of December 6, 2024. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,935.62, is for the delivery of Losartan-HCTZ 100-12.5 mg tablets in 90-count bottles. The contract has an ultimate completion date of February 3, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999...